Literature DB >> 20927672

Family physicians believe the placebo effect is therapeutic but often use real drugs as placebos.

Rachel Kermen1, John Hickner, Howard Brody, Irma Hasham.   

Abstract

BACKGROUND AND OBJECTIVES: Few national data exist on physicians' use of and beliefs about placebos in routine health care.
METHODS: We mailed a 22-question, confidential survey about placebo use and beliefs to a random sample of 1,000 members of the American Academy of Family Physicians.
RESULTS: A total of 412 of 970 (43%) eligible physicians responded, and 56% of respondents said they had used a placebo in clinical practice. Forty percent of respondents had used an antibiotic as a placebo, and 11% had used inert substances. The most common reason for prescribing placebos was "after unjustified demand for medication." Eighty-five percent of respondents believed placebos can have both psychological and physical benefits. The majority (61%) recommended a placebo over offering no treatment, while 8% said clinical placebo use should be categorically prohibited. Nearly all respondents believed a number of routine clinical practices promote the placebo effect.
CONCLUSIONS: Many US family physicians use placebos and generally believe the placebo effect has both psychological and physical benefits. Physicians recognize the broader application of the placebo effect but they commonly use active medication as placebos. The responses to this survey raise important questions about the appropriate use of placebos and the therapeutic value of the placebo effect in clinical practice.

Mesh:

Substances:

Year:  2010        PMID: 20927672

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  20 in total

1.  The placebo phenomenon: implications for the ethics of shared decision-making.

Authors:  Howard Brody; Luana Colloca; Franklin G Miller
Journal:  J Gen Intern Med       Date:  2012-01-19       Impact factor: 5.128

2.  Impure placebo is a useless concept.

Authors:  Pekka Louhiala; Harri Hemilä; Raimo Puustinen
Journal:  Theor Med Bioeth       Date:  2015-08

3.  Primary care providers' use of and attitudes towards placebos: An exploratory focus group study with US physicians.

Authors:  Michael H Bernstein; Cosima Locher; Sif Stewart-Ferrer; Sarah Buergler; Catherine M DesRoches; Michelle L Dossett; Franklin G Miller; Deborah Grose; Charlotte R Blease
Journal:  Br J Health Psychol       Date:  2020-05-30

Review 4.  Harnessing the placebo effect: the need for translational research.

Authors:  Luana Colloca; Franklin G Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

5.  Harnessing the placebo effect in pediatric migraine clinic.

Authors:  Vanda Faria; Clas Linnman; Alyssa Lebel; David Borsook
Journal:  J Pediatr       Date:  2014-07-22       Impact factor: 4.406

Review 6.  Placebos Without Deception: Outcomes, Mechanisms, and Ethics.

Authors:  Luana Colloca; Jeremy Howick
Journal:  Int Rev Neurobiol       Date:  2018-04-04       Impact factor: 3.230

7.  Placebo disclosure does not result in negative changes in mood or attitudes towards health care or the provider.

Authors:  Joel E Bialosky; Michael E Robinson
Journal:  J Man Manip Ther       Date:  2017-03-09

8.  Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial.

Authors:  Anthony Lembo; John M Kelley; Judy Nee; Sarah Ballou; Johanna Iturrino; Vivian Cheng; Vikram Rangan; Jesse Katon; William Hirsch; Irving Kirsch; Kathryn Hall; Roger B Davis; Ted J Kaptchuk
Journal:  Pain       Date:  2021-09-01       Impact factor: 7.926

9.  Patients' attitudes about the use of placebo treatments: telephone survey.

Authors:  Sara Chandros Hull; Luana Colloca; Andrew Avins; Nancy P Gordon; Carol P Somkin; Ted J Kaptchuk; Franklin G Miller
Journal:  BMJ       Date:  2013-07-02

Review 10.  Relieving pain using dose-extending placebos: a scoping review.

Authors:  Luana Colloca; Paul Enck; David DeGrazia
Journal:  Pain       Date:  2016-08       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.